133 related articles for article (PubMed ID: 17079165)
1. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Lin Z; Lei H; Cao P
Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
[TBL] [Abstract][Full Text] [Related]
2. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of recombinant sTRAIL expressed in Escherichia coli.
Xia XX; Shen YL; Wei DZ
Acta Biochim Biophys Sin (Shanghai); 2004 Feb; 36(2):118-22. PubMed ID: 14970907
[TBL] [Abstract][Full Text] [Related]
4. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
[TBL] [Abstract][Full Text] [Related]
5. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Kronbach T; Dettmer D
Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
[TBL] [Abstract][Full Text] [Related]
6. Purification, refolding, and characterization of recombinant LHRH-T multimer.
Raina K; Panda AK; Ali MM; Talwar GP
Protein Expr Purif; 2004 Sep; 37(1):8-17. PubMed ID: 15294275
[TBL] [Abstract][Full Text] [Related]
7. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.
Jin H; Uddin MS; Huang YL; Teo WK
J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497
[TBL] [Abstract][Full Text] [Related]
8. Production and purification of refolded recombinant Plasmodium falciparum beta-ketoacyl-ACP reductase from inclusion bodies.
Karmodiya K; Srivastav RK; Surolia N
Protein Expr Purif; 2005 Jul; 42(1):131-6. PubMed ID: 15939298
[TBL] [Abstract][Full Text] [Related]
9. Purification and on-column refolding of EGFP overexpressed as inclusion bodies in Escherichia coli with expanded bed anion exchange chromatography.
Cabanne C; Noubhani AM; Hocquellet A; Dole F; Dieryck W; Santarelli X
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):23-7. PubMed ID: 15722040
[TBL] [Abstract][Full Text] [Related]
10. On-column refolding of recombinant human interleukin-4 from inclusion bodies.
Razeghifard MR
Protein Expr Purif; 2004 Sep; 37(1):180-6. PubMed ID: 15294296
[TBL] [Abstract][Full Text] [Related]
11. Expression, refolding, and activity of a recombinant nonhemorrhagic snake venom metalloprotease.
Selistre-de-Araujo HS; de Souza EL; Beltramini LM; Ownby CL; Souza DH
Protein Expr Purif; 2000 Jun; 19(1):41-7. PubMed ID: 10833388
[TBL] [Abstract][Full Text] [Related]
12. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
Vallejo LF; Rinas U
Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
[TBL] [Abstract][Full Text] [Related]
13. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
14. Expression of a kallikrein-like protease from the snake venom: engineering of autocatalytic site in the fusion protein to facilitate protein refolding.
Hung CC; Chiou SH
Biochem Biophys Res Commun; 2000 Sep; 275(3):924-30. PubMed ID: 10973823
[TBL] [Abstract][Full Text] [Related]
15. Refolding of the Cupressus arizonica major pollen allergen Cup a1.02 overexpressed in Escherichia coli.
Rea G; Iacovacci P; Ferrante P; Zelli M; Brunetto B; Lamba D; Boffi A; Pini C; Federico R
Protein Expr Purif; 2004 Oct; 37(2):419-25. PubMed ID: 15358365
[TBL] [Abstract][Full Text] [Related]
16. Preparation of recombinant bovine, porcine, and porcine W4R/R5K leptins and comparison of their activity and immunoreactivity with ovine, chicken, and human leptins.
Raver N; Gussakovsky EE; Keisler DH; Krishna R; Mistry J; Gertler A
Protein Expr Purif; 2000 Jun; 19(1):30-40. PubMed ID: 10833387
[TBL] [Abstract][Full Text] [Related]
17. Refolding and purification of Apo2l/TRAIL produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli.
Shen YL; Xia XX; Zhang Y; Liu JW; Wei DZ; Yang SL
Biotechnol Lett; 2003 Dec; 25(24):2097-101. PubMed ID: 14969416
[TBL] [Abstract][Full Text] [Related]
18. [Regulation of soluble TRAIL and membrane TRAIL in Jurkat cells by PMA].
Li Y; Cao YX; Zhang Y; Song CJ; Zhuang R; Fang L; Jin BQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):276-9. PubMed ID: 15862138
[TBL] [Abstract][Full Text] [Related]
19. In vitro refolding of carboxypeptidase T precursor from Thermoactinomyces vulgaris obtained in Escherichia coli as cytoplasmic inclusion bodies.
Trachuk L; Letarov A; Kudelina IA; Yusupova MP; Chestukhina GG
Protein Expr Purif; 2005 Mar; 40(1):51-9. PubMed ID: 15721771
[TBL] [Abstract][Full Text] [Related]
20. Construction and overexpression of a synthetic gene for human DNA methylguanine methyltransferase: renaturation and rapid purification of the protein.
Brown LR; Deng J; Noll DM; Mori N; Clarke ND
Protein Expr Purif; 1997 Apr; 9(3):337-45. PubMed ID: 9126605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
